| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 18.848 | 103.156 | 161.453 |
| Total Income - EUR | - | - | - | - | - | - | - | 18.848 | 103.159 | 161.493 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 9.733 | 112.401 | 162.746 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 9.116 | -9.242 | -1.253 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 8.550 | -10.287 | -5.241 |
| Employees | - | - | - | - | - | - | - | 2 | 3 | 3 |
Check the financial reports for the company - Zaya Pathology Diagnostic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 2.191 |
| Current Assets | - | - | - | - | - | - | - | 9.168 | 16.596 | 26.880 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 8.177 | 12.512 | 22.756 |
| Cash | - | - | - | - | - | - | - | 992 | 4.083 | 4.124 |
| Shareholders Funds | - | - | - | - | - | - | - | 8.753 | -1.560 | -6.792 |
| Social Capital | - | - | - | - | - | - | - | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | - | 415 | 18.156 | 35.863 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Zaya Pathology Diagnostic S.r.l.